Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oncologic Safety and Lymphadenectomy in Parenchyma-Sparing Resection for SPN
Sponsor: Fudan University
Summary
Solid pseudopapillary neoplasm (SPN) of the pancreas is a low-grade malignant tumor primarily treated with surgical resection. However, the oncologic safety of parenchyma-sparing resection (PSR) and the necessity of lymphadenectomy remain debated. This prospective cohort study evaluates these aspects based on long-term outcomes.
Official title: Parenchyma-Sparing Resection for Pancreatic Solid Pseudopapillary Neoplasm: Oncologic Safety and Role of Lymphadenectomy in a Prospective Cohort Study
Key Details
Gender
All
Age Range
14 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
708
Start Date
2008-07-01
Completion Date
2026-03-01
Last Updated
2026-05-18
Healthy Volunteers
No
Interventions
Parenchyma-sparing resection
PSR included enucleation (EN), duodenum-preserving pancreatic head resection (DPPHR), central pancreatectomy (CP), and spleen-preserving distal pancreatectomy (SPDP). OR included pancreatoduodenectomy (PD), distal pancreatectomy with splenectomy (DPS), and total pancreatectomy (TP).
Locations (1)
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China